Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 158.50
-0.70 (-0.44%)
Sep 9, 2026, 5:35 PM CET
Ipsen Market Cap
Ipsen has a market cap or net worth of €13.05 billion as of September 9, 2026. Its market cap has increased by 33.25% in one year.
Market Cap
13.05B
Enterprise Value
12.05B
Revenue
4.29B
Ranking
n/a
PE Ratio
25.80
Stock Price
€158.50
ChartMarket Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 13.05B, an increase of 634.96%. That is a compound annual growth rate of 10.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 13.00B | 33.01% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 90.68B |
| EssilorLuxottica Société anonyme | 68.27B |
| Sartorius Stedim Biotech | 18.15B |
| Eurofins Scientific SE | 12.43B |
| bioMérieux | 8.54B |
| ABIVAX Société Anonyme | 8.54B |
| Virbac | 2.63B |
| emeis Société anonyme | 2.04B |